INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • February 19th, 2021 • Medicus Sciences Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionThis Investment Management Trust Agreement (this “Agreement”) is made effective as of February 15, 2021 by and between Medicus Sciences Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (the “Trustee”).
February 15, 2021 Medicus Sciences Acquisition Corp. New York, New York 10019Letter Agreement • February 19th, 2021 • Medicus Sciences Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionThis letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Medicus Sciences Acquisition Corp., a Cayman Islands exempted company (the “Company”) and Maxim Group LLC, as representative (the “Representative”) of the several underwriters (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of 9,200,000 of the Company’s units (including 1,200,000 units that may be purchased pursuant to the Underwriters’ option to purchase additional units, the “Units”), each unit consisting of (i) one Class A ordinary share of the Company, par value $0.0001 per share (collectively, the “Ordinary Shares”), (ii) one-ninth of one redeemable warrant (the “outstanding redeemable warrants”) and (iii) the contingent right to receive, in certain circumstances, following the initial business combination redemption time, at least two-ninths of one redeemable warra
WARRANT AGREEMENT between MEDICUS SCIENCES ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated February 15, 2021Warrant Agreement • February 19th, 2021 • Medicus Sciences Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionTHIS WARRANT AGREEMENT (this “Agreement”), dated February 15, 2021, is by and between Medicus Sciences Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (in such capacity, the “Warrant Agent”).
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENTPrivate Placement Warrants Purchase Agreement • February 19th, 2021 • Medicus Sciences Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionTHIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this "Agreement"), dated as of February 15, 2021, is entered into by and between Medicus Sciences Acquisition Corp., a Cayman Islands exempted company (the "Company"), and Medicus Sciences Holdings LLC, a Delaware limited liability company (the "Purchaser").
8,000,000 Units Medicus Sciences Acquisition Corp. UNDERWRITING AGREEMENTUnderwriting Agreement • February 19th, 2021 • Medicus Sciences Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionThe undersigned, Medicus Sciences Acquisition Corp., a Cayman Islands corporation (“Company”), hereby confirms its agreement with Maxim Group LLC (hereinafter referred to as “you”, “Maxim”, or as the “Representative”) and with the other underwriters named on Schedule A hereto for which you are acting as representative (the Representative and the other Underwriters being collectively referred to herein as the “Underwriters” or, individually, an “Underwriter”), as follows:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 19th, 2021 • Medicus Sciences Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of February 15, 2021, is made and entered into by and among Medicus Sciences Acquisition Corp., a Cayman Islands exempted company (the "Company"), Medicus Sciences Holdings LLC, a Delaware limited liability company (the "Sponsor"), Maxim Partners LLC ("Maxim") and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a "Holder" and collectively the "Holders").
CONTINGENT RIGHTS AGREEMENTContingent Rights Agreement • February 19th, 2021 • Medicus Sciences Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionThis Contingent Rights Agreement (this “Agreement”) is made as of February 15, 2021 between Medicus Sciences Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, with offices at 1 State Street, New York, New York 10004 (the “Rights Agent”).
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENTPrivate Placement Warrants Purchase Agreement • February 19th, 2021 • Medicus Sciences Acquisition Corp. • Blank checks • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionTHIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of February 15, 2021, is entered into by and between Medicus Sciences Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Maxim Partners LLC (the “Purchaser”).
Medicus Sciences Acquisition Corp.Medicus Sciences Acquisition Corp. • February 19th, 2021 • Blank checks • New York
Company FiledFebruary 19th, 2021 Industry JurisdictionThis letter agreement by and between Medicus Sciences Acquisition Corp. (the “Company”) and Medicus Sciences Holdings LLC (“MSH”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities of the Company are first listed on The Nasdaq Capital Market (the “Listing Date”), pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):